Cargando…
Diagnostic and prognostic value of HABP2 as a novel biomarker for endometrial cancer
BACKGROUND: Endometrial cancer is the fifth most common malignant disorder in women, with its incidence increasing. A biomarker with diagnostic and prognostic value remains to be found. The HABP2 protein, or Factor VII-activating protease, encodes a hyaluronic acid-binding protein. METHODS: Patient...
Autores principales: | Jiang, Ying, Li, Jinfeng, Sang, Cuiqin, Cao, Guangming, Wang, Shuzhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576057/ https://www.ncbi.nlm.nih.gov/pubmed/33241013 http://dx.doi.org/10.21037/atm-20-5744 |
Ejemplares similares
-
HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer Progression
por: Mirzapoiazova, Tamara, et al.
Publicado: (2015) -
HABP2 germline variants are uncommon in familial nonmedullary thyroid cancer
por: Weeks, Alexia L., et al.
Publicado: (2016) -
Bioinformatic screening for candidate biomarkers and their prognostic values in endometrial cancer
por: Li, Yaowei, et al.
Publicado: (2020) -
HABP2 G534E Variant in Papillary Thyroid Carcinoma
por: Tomsic, Jerneja, et al.
Publicado: (2016) -
Identification of novel diagnostic and prognostic miRNA signatures in endometrial cancer
por: Jayaraman, Muralidharan, et al.
Publicado: (2017)